Molecule Structure

Scientific Name

Olaparib

Description of the Drug

Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09074

Brand Name(s)

Lynparza

Company Owner(s)

Astrazeneca Pharmaceuticals Lp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
PARP 1, 2 and 3 PROTEIN FAMILY INHIBITOR CHEMBL3390820

Unichem Links

SureChEMBL SCHEMBL426568
Human Metabolome Database HMDB0255929
DrugBank DB09074
PubChem: Thomson Pharma 47209066
PubChem 23725625
LINCS LSM-1145
Nikkaji J2.765.098H
PDBe 09L
BindingDB 27566
DrugCentral 4907
Brenda 209563
ChemicalBook CB02473811 CB02756176
Guide to Pharmacology 7519
rxnorm OLAPARIB LYNPARZA
PubChem: Drugs of the Future 85197660
ChEBI 83766
ZINC ZINC000040430143